Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.21 | 1e-05 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0006 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.002 |
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |